Lab
Tampa Bay Diagnostic Institute, LLC
Tampa Bay Diagnostic Institute, LLC was paid $900K by Medicaid between May 2022 and Oct 2024, across 42 billing codes. Its largest line is 87637, Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV — 60% of everything it billed.
33Billing provider infoTAMPA BAY DIAGNOSTIC INSTITUTE, LLC
PLANT CITY, FL 33563
PLANT CITY, FL 33563
33aNPI1316614175assigned 08/27/2021
33bProvider typeClinical Medical Laboratory
28Total paid$900K
24GClaims32,490
24DCodes billed42
24AFirst – last monthMay 2022 – Oct 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Florida
Rank by total paid#45 of 225
Median peer was paid$74K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 6,694 | $254K | |
| 2023 | 13,286 | $634K | |
| 2024incomplete | 12,510 | $12K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 60% | 5,816 | 2,618 | $539K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 10% | 7,950 | 3,400 | $91K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 9.2% | 1,388 | 649 | $82K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 8.3% | 1,004 | 412 | $75K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.7% | 1,305 | 549 | $51K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 5.6% | 2,308 | 1,013 | $50K |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | <1% | 57 | 57 | $6K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 288 | 207 | $2K |
| 87481 | <1% | 304 | 205 | $643.39 | |
| 80053 | Comprehensive metabolic panel | <1% | 1,540 | 741 | $551.56 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,231 | 987 | $509.54 |
| 87653 | <1% | 285 | 197 | $238.62 |
30 more codes
| 83880 | <1% | 78 | $234.23 | |
| 87641 | <1% | 288 | $192.59 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 321 | $165.40 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 341 | $161.22 |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | <1% | 2,123 | $158.26 |
| 87581 | <1% | 177 | $134.89 | |
| 87500 | <1% | 237 | $117.86 | |
| 80047 | <1% | 525 | $106.47 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 81 | $94.96 |
| 81003 | <1% | 416 | $84.38 | |
| 82140 | <1% | 71 | $71.68 | |
| 85027 | <1% | 127 | $57.15 | |
| 82746 | <1% | 76 | $46.98 | |
| 87563 | <1% | 64 | $43.69 | |
| 83735 | <1% | 246 | $43.06 | |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | <1% | 1,743 | $40.00 |
| 82607 | <1% | 81 | $38.10 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 20 | $35.56 |
| 81001 | <1% | 273 | $29.63 | |
| 87640 | <1% | 122 | $18.94 | |
| 80164 | <1% | 36 | $18.30 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 110 | $16.47 |
| 87540 | <1% | 13 | $11.88 | |
| 84439 | <1% | 18 | $9.85 | |
| 84466 | <1% | 36 | $9.08 | |
| 82728 | <1% | 42 | $8.48 | |
| 80061 | Lipid panel | <1% | 180 | $8.47 |
| 87184 | <1% | 64 | $7.85 | |
| 87551 | <1% | 27 | $5.21 | |
| 83037 | <1% | 78 | $4.86 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHANDLER, MATTHEW (OWNER)